Effective management prioritized by Oncology Venture’s Chairman
Last week, BioStock talked to Oncology Venture’s new CEO Steve Carchedi about his vision for the company going forward. Today, we pick up the conversation with the company’s chairman, Duncan Moore. How does he use his past experience from companies like Morgan Stanley when such key recruitments are made? Learn more about his strategies and […].